Celltrion
068270.KS
#744
Rank
NZ$54.32 B
Marketcap
NZ$248.31
Share price
1.40%
Change (1 day)
19.97%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

ESG Reports

Thumbnail Celltrion
 ESG Report 2023-2024

ESG Report 2023-2024

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2022-2023

ESG Report 2022-2023

Language: English

View ESG Report